|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 1650 Diagonal Road |
Address2 |
|
City | ALEXANDRIA |
State | VA |
Zip Code | 22314 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 1386-12
|
||||||||
|
6. House ID# 321810000
|
TYPE OF REPORT | 8. Year | 2023 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: John Aguilar |
Date | 1/18/2024 1:23:07 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
December 21, 2023 coalition letter to the Food and Drug Administration (FDA) on the issue of communications from firms to health care providers regarding scientific information on unapproved uses of approved/cleared medical products.
December 20, 2023 letter led by the AAO-HNS and signed by 111 physician organizations to the Senate Finance Committee expressing strong opposition to the Medicare Audiology Access Improvement Act (S. 2377).
November 30, 2023 coalition letter to the Medicare Payment Advisory Commission (MedPAC) on assessing and updating Medicare payment for physicians in calendar year 2025.
November 16, 2023 coalition letter to Congressional Leadership urging them to pass legislation to prevent the pending 3.37% cut to Medicare physician payment that will go into effect in January 2024.
October 31, 2023 coalition letter to Representatives Brad Wenstrup, Greg Murphy, and Michael Burgess in support of their legislative proposal to reform the budget-neutrality proposals that have been eroding Medicare physician payment.
October 30, 2023 coalition letter to the House Energy and Commerce Committee and the Senate HELP Committee expressing concern about the Department of Health and Human Services recent proposed rule on nondiscrimination in health programs and activities.
October 19, 2023 coalition letter to the House Energy and Commerce Committee providing feedback on legislation considered for its hearing entitled Whats the Prognosis? Examining Medicare Proposals to Improve Patient Access to Care and Minimize Red Tape for Doctors.
October 15, 2023 coalition letter to the House Budget Committee in response to their Request for Information (RFI) on ways to improve health outcomes while reducing federal health care spending.
October 13, 2023 letter to the House Budget Committee in response to their Request for Information (RFI) on ways to improve health outcomes while reducing federal health care spending.
Issues pertaining to scope of practice legislation, related to the Medicare Audiology Access Improvement Act of 2023 (S. 2733 / H.R. 6445), and in general
Issues pertaining to prior authorization, in general
Issues pertaining to Medicare physician reimbursement, related to the Strengthening Medicare for Patients and Providers Act (H.R. 2474) and the Preserving Seniors Access to Physicians Act of 2023 (H.R. 6683), and in general.
Issues related to hearing healthcare, in general.
Issues pertaining to health information technology and electronic health records, in general.
Issues pertaining to Language Equality and Acquisition for Deaf Kids (LEAD-K) and parent choice, in general.
Issues pertaining to Graduate Medical Education, in general.
Issues pertaining to healthcare liability reform, in general.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Food & Drug Administration (FDA), Centers For Medicare and Medicaid Services (CMS), Health Resources & Services Administration (HRSA), Medicare Payment Advisory Commission (MedPAC)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Maura |
Farrell |
|
|
|
John |
Aguilar |
|
|
|
Harry |
DeCabo |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
December 20, 2023 letter led by the AAO-HNS and signed by 111 physician organizations to the Senate Finance Committee expressing strong opposition to the Medicare Audiology Access Improvement Act (S. 2377).
November 30, 2023 coalition letter to the Medicare Payment Advisory Commission (MedPAC) on assessing and updating Medicare payment for physicians in calendar year 2025.
November 16, 2023 coalition letter to Congressional Leadership urging them to pass legislation to prevent the pending 3.37% cut to Medicare physician payment that will go into effect in January 2024.
October 31, 2023 coalition letter to Representatives Brad Wenstrup, Greg Murphy, and Michael Burgess in support of their legislative proposal to reform the budget-neutrality proposals that have been eroding Medicare physician payment.
October 30, 2023 coalition letter to the House Energy and Commerce Committee and the Senate HELP Committee expressing concern about the Department of Health and Human Services recent proposed rule on nondiscrimination in health programs and activities.
October 19, 2023 coalition letter to the House Energy and Commerce Committee providing feedback on legislation considered for its hearing entitled Whats the Prognosis? Examining Medicare Proposals to Improve Patient Access to Care and Minimize Red Tape for Doctors.
October 15, 2023 coalition letter to the House Budget Committee in response to their Request for Information (RFI) on ways to improve health outcomes while reducing federal health care spending.
October 13, 2023 letter to the House Budget Committee in response to their Request for Information (RFI) on ways to improve health outcomes while reducing federal health care spending.
Issues pertaining to scope of practice legislation, related to the Medicare Audiology Access Improvement Act of 2023 (S. 2733 / H.R. 6445), and in general
Issues pertaining to prior authorization, in general
Issues pertaining to the Early Hearing Detection and Intervention Program, in general
Issues pertaining to Medicare physician reimbursement, related to the Strengthening Medicare for Patients and Providers Act (H.R. 2474) and the Preserving Seniors Access to Physicians Act of 2023 (H.R. 6683), and in general.
Issues related to hearing healthcare, in general.
Issues pertaining to health information technology and electronic health records, in general.
Issues pertaining to Graduate Medical Education, in general.
Issues pertaining to healthcare liability reform, in general
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Medicare Payment Advisory Commission (MedPAC)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Maura |
Farrell |
|
|
|
John |
Aguilar |
|
|
|
Harry |
DeCabo |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOB
16. Specific lobbying issues
Issues pertaining to tobacco control, including the pending FDA rule on prohibiting menthol cigarettes, and in general.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Food & Drug Administration (FDA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Maura |
Farrell |
|
|
|
John |
Aguilar |
|
|
|
Harry |
DeCabo |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code VET
16. Specific lobbying issues
Issues pertaining to healthcare practice and the Federal Supremacy Clause at the Department of Veterans Affairs, in general.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Veterans Affairs - Dept of (VA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Maura |
Farrell |
|
|
|
John |
Aguilar |
|
|
|
Harry |
DeCabo |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Issues pertaining to the budget and appropriations, in general.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Maura |
Farrell |
|
|
|
John |
Aguilar |
|
|
|
Harry |
DeCabo |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
Lobbyist Name | Description of Offense(s) |